Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP321026.RAbyMZg1IAB6Slg3d-7j7fPnQ8FpYFnmYCZfNXQnN6xEY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP321026.RAbyMZg1IAB6Slg3d-7j7fPnQ8FpYFnmYCZfNXQnN6xEY130_assertion type Assertion NP321026.RAbyMZg1IAB6Slg3d-7j7fPnQ8FpYFnmYCZfNXQnN6xEY130_head.
- NP321026.RAbyMZg1IAB6Slg3d-7j7fPnQ8FpYFnmYCZfNXQnN6xEY130_assertion description "[These findings suggest that inactivation of pRB and/or p16 is a major event in human hepatocarcinogenesis, while cyclin D1 overexpression may confer additional growth advantages to the tumor in addition to pRB and/or p16 inactivation in HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321026.RAbyMZg1IAB6Slg3d-7j7fPnQ8FpYFnmYCZfNXQnN6xEY130_provenance.
- NP321026.RAbyMZg1IAB6Slg3d-7j7fPnQ8FpYFnmYCZfNXQnN6xEY130_assertion evidence source_evidence_literature NP321026.RAbyMZg1IAB6Slg3d-7j7fPnQ8FpYFnmYCZfNXQnN6xEY130_provenance.
- NP321026.RAbyMZg1IAB6Slg3d-7j7fPnQ8FpYFnmYCZfNXQnN6xEY130_assertion SIO_000772 11408803 NP321026.RAbyMZg1IAB6Slg3d-7j7fPnQ8FpYFnmYCZfNXQnN6xEY130_provenance.
- NP321026.RAbyMZg1IAB6Slg3d-7j7fPnQ8FpYFnmYCZfNXQnN6xEY130_assertion wasDerivedFrom befree-2016 NP321026.RAbyMZg1IAB6Slg3d-7j7fPnQ8FpYFnmYCZfNXQnN6xEY130_provenance.
- NP321026.RAbyMZg1IAB6Slg3d-7j7fPnQ8FpYFnmYCZfNXQnN6xEY130_assertion wasGeneratedBy ECO_0000203 NP321026.RAbyMZg1IAB6Slg3d-7j7fPnQ8FpYFnmYCZfNXQnN6xEY130_provenance.